Clinical Trial Update: Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of PRI-724 in combination with gemcitabine in patients with advanced or metastatic pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PRI-724 (PRI-724)

Snippet

Sponsor: Prism Pharma Co., Ltd. | Conditions: Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 1 | Status: COMPLETED